Paraoxonase-1 enzyme activity assay for clinical samples: Validation and correlation studies

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 902-908

  Garelnabi, Mahdi ^a   Younis, Abdelmoneim ^b  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^b MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biochemical processes; Cardiovascular diseases; Enzyme activation

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; BIOLOGICAL MARKER; CITRATE TRISODIUM; EDETIC ACID; GLUTATHIONE PEROXIDASE; HEPARIN; SODIUM FLUORIDE; ANTICOAGULANT AGENT; ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BLOOD COLLECTION TUBE; BLOOD SAMPLING; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HEMOLYSIS; HUMAN; LINEARITY; MEASUREMENT PRECISION; STORAGE TEMPERATURE; VALIDATION STUDY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; NONPARAMETRIC TEST; PROCEDURES; REPRODUCIBILITY;

ADULT; ANTICOAGULANTS; ARYLDIALKYLPHOSPHATASE; ENZYME ASSAYS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOLYSIS; HUMANS; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC;

EID: 84925936052     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.892668     Document Type: Article

References (19)

1. Litvinov D, Mahini H, Garelnabi M: Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases. N Am J Med Sci, 2012; 4(11): 523–32
2. Liu H, Xia P, Liu M et al: PON gene polymorphisms and ischaemic stroke: a systematic review and meta-analysis. Int J Stroke, 2013; 8(2): 111–23
3. Rosenblat M, Grunfeld O, Hayek T, Aviram M: Serum paraoxonase activity and the extent of lipid peroxidation are not affected by increased levels of human apolipoprotein A-I: studies in transgenic mice. Clin Chem Lab Med, 2002; 40(1): 9–14
4. Begcevic I, Simundic AM, Nikolac N et al: Can cranberry extract and vitamin C + Zn supplements affect the in vivo activity of paraoxonase 1, anti-oxidant potential, and lipid status? Clin Lab, 2013; 59(9–10): 1053–60
5. Abbott CA, Mackness MI, Kumar S et al: Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol, 1995; 15: 1812–18
6. Richter RJ, Jarvik GP, Furlong CE: Paraoxonase 1 status as a risk factor for disease or exposure. Adv Exp Med Biol, 2010; 660: 29–35
7. Mackness MI, Durrington PN, Mackness B: The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention. Am J Cardiovasc Drugs, 2004; 4(4): 211–17
8. Mackness B, Durrington PN, Mackness MI: Human serum paraoxonase. Gen Pharmacol, 1998; 31(3): 329–36
9. Jaichander P, Selvarajan K, Garelnabi M, Parthasarathy S: Induction of para-oxonase 1 and apolipoprotein A-I gene expression by aspirin. J Lipid Res, 2008; 49(10): 2142–48
10. Younis A, Clower C, Nelsen D et al: The relationship between pregnancy and oxidative stress markers on patients undergoing ovarian stimulations. J Assist Reprod Genet, 2012; 29(10): 1083–89
11. Aviram M, Rosenblat M, Bisgaier CL et al: Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxida-tive role for paraoxonase. J Clin Invest, 1998; 101(8): 1581–90
12. Garelnabi MO, Brown WV, Le NA: Evaluation of a novel colorimetric assay for free oxygen radicals as marker of oxidative stress. Clin Biochem, 2008; 41(14–15): 1250–54
13. Theodorsson E: Validation and verifcation of measurement methods in clinical chemistry. Bioanalysis, 2012; 4(3): 305–20
14. Rossi G, Giordano A, Pezzia F et al: Serum paraoxonase 1 activity in dogs: preanalytical and analytical factors and correlation with C-reactive protein and alpha-2-globulin. Vet Clin Pathol, 2013; 42(3): 329–41
15. Tvarijonaviciute A, Tecles F, Caldin M et al: Validation of spectrophotomet-ric assays for serum paraoxonase type-1 measurement in dogs. Am J Vet Res, 2012; 73(1): 34–41
16. Bossuyt PM, Irwig L, Craig J, Glasziou P: Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ, 2006; 332(7549): 1089–92; Erratum in: BMJ, 2006; 332(7554): 1368
17. Richter R, Furlong C, Eskenazi B, Holland N: Validation of PON1 enzyme activity assays for longitudinal studies. Clin Chim Acta, 2009; 402(1–2): 67–74
18. Desai S, Baker SS, Liu W et al: Paraoxonase 1 and oxidative stress in pae-diatric non-alcoholic steatohepatitis. Liver Int, 2014; 34(1): 110–17
19. Krzystek-Korpacka M, Patryn E, Hotowy K et al: Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress. Adv Clin Exp Med, 2013; 22(2): 229–36